|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
103,650,000 |
Market
Cap: |
1.71(B) |
Last
Volume: |
1,107,565 |
Avg
Vol: |
1,681,610 |
52
Week Range: |
$11.5 - $17.29 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 604 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
50,000 |
304,000 |
304,000 |
4,223,516 |
Total Sell Value |
$803,000 |
$4,338,050 |
$4,338,050 |
$62,649,148 |
Total People Sold |
2 |
6 |
6 |
12 |
Total Sell Transactions |
2 |
8 |
8 |
53 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Grande Alicia |
Chief Accounting Officer |
|
2008-11-24 |
4 |
B |
$1.85 |
$1,850 |
D/D |
1,000 |
7,346 |
2.66 |
- |
|
Coelho Philip H |
Director |
|
2008-11-24 |
4 |
B |
$1.86 |
$5,953 |
D/D |
3,000 |
258,682 |
2.39 |
- |
|
O'keeffe Charles B |
Director |
|
2008-11-20 |
4 |
B |
$2.19 |
$10,793 |
D/D |
4,900 |
63,876 |
2.39 |
- |
|
Coelho Philip H |
Director |
|
2008-11-11 |
4 |
B |
$2.38 |
$1,199 |
D/D |
500 |
255,682 |
2.31 |
- |
|
O'keeffe Charles B |
Director |
|
2008-10-30 |
4 |
B |
$2.32 |
$463 |
D/D |
200 |
58,976 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-10-30 |
4 |
B |
$2.49 |
$2,497 |
D/D |
1,000 |
255,182 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-10-28 |
4 |
B |
$2.53 |
$1,349 |
D/D |
500 |
254,182 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-10-27 |
4 |
B |
$2.60 |
$1,328 |
D/D |
500 |
253,682 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-10-23 |
4 |
B |
$2.68 |
$2,691 |
D/D |
1,000 |
253,182 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-10-21 |
4 |
B |
$2.69 |
$1,345 |
D/D |
500 |
252,182 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-10-15 |
4 |
B |
$2.49 |
$2,565 |
D/D |
1,000 |
251,682 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-10-13 |
4 |
B |
$2.35 |
$2,755 |
D/D |
1,100 |
250,682 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-10-10 |
4 |
B |
$2.27 |
$2,270 |
D/D |
1,000 |
249,582 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-10-08 |
4 |
B |
$2.73 |
$1,365 |
D/D |
500 |
248,582 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-10-06 |
4 |
B |
$2.80 |
$1,400 |
D/D |
500 |
248,082 |
2.31 |
- |
|
Weinstein Jack |
V.P., Treasurer & CFO |
|
2008-10-02 |
4 |
B |
$3.03 |
$303 |
D/D |
100 |
10,493 |
2.66 |
- |
|
Coelho Philip H |
Director |
|
2008-09-29 |
4 |
B |
$2.80 |
$1,129 |
D/D |
400 |
247,582 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-09-26 |
4 |
B |
$2.80 |
$2,800 |
D/D |
1,000 |
247,182 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2008-09-25 |
4 |
B |
$2.65 |
$9,445 |
D/D |
3,300 |
246,182 |
2.39 |
- |
|
Weinstein Jack |
V.P., Treasurer & CFO |
|
2008-09-25 |
4 |
B |
$2.90 |
$1,165 |
D/D |
400 |
10,393 |
2.66 |
- |
|
Mcenany Patrick J |
President and CEO |
|
2008-09-24 |
4 |
B |
$2.35 |
$28,213 |
D/D |
11,900 |
3,079,654 |
3.23 |
- |
|
Mcenany Patrick J |
President and CEO |
|
2008-09-18 |
4 |
B |
$2.50 |
$1,000 |
D/D |
400 |
3,067,754 |
3.15 |
- |
|
Mcenany Patrick J |
President and CEO |
|
2008-09-17 |
4 |
B |
$2.50 |
$5,093 |
D/D |
2,001 |
3,067,354 |
3.15 |
- |
|
Weinstein Jack |
V.P., Treasurer & CFO |
|
2008-09-17 |
4 |
B |
$2.50 |
$7,609 |
D/D |
3,000 |
9,993 |
2.74 |
- |
|
Mcenany Patrick J |
Chairman, President and CEO |
|
2008-07-01 |
4 |
D |
$3.38 |
$1,403 |
D/D |
(415) |
3,065,353 |
|
- |
|
434 Records found
|
|
Page 16 of 18 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|